Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Neurocrine Biosciences Inc

NASDAQ: NBIX · Life Sciences · 4 alerts · CIK 914475

Share price
$165.31Close, Nov 16
Market cap
$16.7B
Shares outstanding
101.22MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Neurocrine Biosciences Inc filings on SEC EDGAR ↗

4:21 PM ET 8-K
Leadership Change

Neurocrine Biosciences Leadership Change

Neurocrine Biosciences appointed Eiry W. Roberts, M.D., as Chief Medical Officer, succeeding Sanjay Keswani, M.D., effective September 28, 2026. Dr. Roberts will receive an annual base salary of $825,000, a 60% target bonus, and equity grants totaling approximately $1.25 million in target value. Dr. Keswani's departure was described as a mutual agreement, and he will receive severance benefits under the company's existing executive plan.

Counterparty
Eiry W. Roberts, M.D.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.